MX356184B - Fórmulación pediátrica sintética que comprende un probiótico. - Google Patents

Fórmulación pediátrica sintética que comprende un probiótico.

Info

Publication number
MX356184B
MX356184B MX2013007675A MX2013007675A MX356184B MX 356184 B MX356184 B MX 356184B MX 2013007675 A MX2013007675 A MX 2013007675A MX 2013007675 A MX2013007675 A MX 2013007675A MX 356184 B MX356184 B MX 356184B
Authority
MX
Mexico
Prior art keywords
human milk
milk oligosaccharides
probiotic
promote growth
beneficial microbiota
Prior art date
Application number
MX2013007675A
Other languages
English (en)
Other versions
MX2013007675A (es
Inventor
Chow Jomay
Buck Rachael
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2013007675A publication Critical patent/MX2013007675A/es
Publication of MX356184B publication Critical patent/MX356184B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a el uso de una fórmula pediátrica sintética que comprende un probiótico, un primer oligosacárido en una concentración de 1 mg/ml a 4 mg/ml y seleccionado del grupo que consiste de un galactooligosacárido un fructooligosacárido, y combinaciones de los mismos; y un oligosacárido de leche humana en una concentración de 0.05 mg/ml a 0.5 mg/ml y seleccionado del grupo que consiste de 3´-fucosillactosa o 2´-fucosillactosa y lacto-N-neotetraosa, y combinaciones de las mismas en la fabricación de un medicamento para estimular las células nerviosas entéricas y producir ácidos grasos de cadena corta en el tracto gastrointestinal de un individuo.
MX2013007675A 2010-12-31 2011-12-22 Fórmulación pediátrica sintética que comprende un probiótico. MX356184B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061428869P 2010-12-31 2010-12-31
PCT/US2011/067012 WO2012092155A1 (en) 2010-12-31 2011-12-22 Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota

Publications (2)

Publication Number Publication Date
MX2013007675A MX2013007675A (es) 2013-07-29
MX356184B true MX356184B (es) 2018-05-17

Family

ID=45529204

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007675A MX356184B (es) 2010-12-31 2011-12-22 Fórmulación pediátrica sintética que comprende un probiótico.

Country Status (11)

Country Link
US (1) US20120171166A1 (es)
EP (2) EP2658402A1 (es)
CN (1) CN103763940B (es)
BR (1) BR112013016914A2 (es)
CA (1) CA2822660C (es)
HK (1) HK1256876A1 (es)
MX (1) MX356184B (es)
NZ (1) NZ612386A (es)
SG (1) SG191798A1 (es)
TW (1) TW201304692A (es)
WO (1) WO2012092155A1 (es)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2821935A1 (en) 2010-12-29 2012-07-05 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
SG191393A1 (en) * 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
SG10201603856PA (en) 2010-12-31 2016-07-28 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
DK2658549T3 (da) 2010-12-31 2020-06-29 Abbott Lab Fremgangsmåder til reduktion af incidensen af oxidativt stress under anvendelse af humane mælkeoligosaccharider, vitamin c og anti-inflammatoriske midler
BR112013020108A2 (pt) * 2011-02-10 2017-06-13 Nestec Sa modulação do crescimento de bifidobactérias usando uma combinação de oligossacarídeos encontrados no leite de ser humano
WO2013016111A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
SG2014013478A (en) 2011-08-29 2014-05-29 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
DK2708145T3 (en) 2012-09-14 2016-07-18 Abbott Lab Nutritional Compositions for Use in Methods to Modulate Corticosterone Levels in Psychologically Stressed Individuals
ES2795665T3 (es) * 2012-09-14 2020-11-24 Abbott Lab Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa
EP2745705A1 (en) * 2012-12-18 2014-06-25 Abbott Laboratories Nutritional use of human milk oligosaccharides
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
US20150352162A1 (en) * 2013-01-21 2015-12-10 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
AU2014225786B2 (en) 2013-03-08 2017-10-12 Axiom Foods, Inc. Rice protein supplements
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
WO2014200334A1 (en) * 2013-06-14 2014-12-18 N.V. Nutricia Synbiotic composition for treatment of infections in allergic patients
AU2014368585A1 (en) * 2013-12-19 2016-05-19 Nestec S.A. Nutritional composition for use in reducing metabolic stress in infants, decreasing gut permeability and approximating growth rate of breast-fed infants
CN106132420A (zh) 2014-04-08 2016-11-16 雅培公司 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
CA2965663C (en) 2014-10-24 2023-04-04 Evolve Biosystems, Inc. Activated bifidobacteria and methods of use thereof
US20170258820A1 (en) * 2014-10-29 2017-09-14 Glycom A/S Synthetic composition and method for promoting mucosal healing
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
EP3212197A4 (en) * 2014-10-29 2018-07-11 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
EP3229812A4 (en) * 2014-12-08 2018-10-03 Glycom A/S Synthetic composition for treating metabolic disorders
CN104528149A (zh) * 2014-12-31 2015-04-22 福建美力生生物科技股份有限公司 一种即用型益生菌饮料产品
ES2952585T3 (es) * 2015-01-14 2023-11-02 Infant Bacterial Therapeutics Ab Preparado de lactobacillus reuteri y citrato para uso médico
AU2016227595B2 (en) * 2015-03-05 2020-08-27 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children
ES2772685T3 (es) * 2015-08-04 2020-07-08 Nestle Sa Composiciones nutricionales con 2FL y LNNT para inducir una microbiota intestinal similar a la de los bebés lactantes
ES2879985T3 (es) * 2015-08-04 2021-11-23 Nestle Sa Composiciones nutritivas y fórmulas infantiles que comprenden Bifidobacterium animalis ssp. lactis y, opcionalmente, una mezcla de oligosacáridos para inducir una microbiota intestinal cercana a la de bebés alimentados por lactancia materna
DK3349763T3 (en) * 2015-09-14 2021-11-15 Glycom As Composition for use in microbiota modulation
WO2017071716A1 (en) 2015-10-28 2017-05-04 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
CN108495635A (zh) * 2016-01-26 2018-09-04 雀巢产品技术援助有限公司 人乳低聚糖对抗日后的脂肪量过度积聚和相关的健康障碍
EP3407739B1 (en) * 2016-01-26 2021-06-23 Société des Produits Nestlé S.A. Composition for use in the prevention and/or treatment of skin conditions and skin diseases
CN108495562A (zh) * 2016-01-26 2018-09-04 雀巢产品技术援助有限公司 具有特异性低聚糖的用于预防或治疗变态反应的组合物
CN108495636A (zh) * 2016-01-26 2018-09-04 雀巢产品技术援助有限公司 通过预防过早肥胖反弹而对健康有益的人乳低聚糖
US11224651B2 (en) 2016-01-26 2022-01-18 Societe Des Produits Nestle S.A. Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
WO2017156550A1 (en) * 2016-03-11 2017-09-14 Evolve Biosystems Inc. A transient commensal microorganism for improving gut health
WO2017190754A1 (en) * 2016-05-05 2017-11-09 Glycom A/S Composition comprising hmos for the treatment of non-infectious diarrhoea
EP3458073B1 (en) * 2016-05-19 2023-10-25 Glycom A/S Use of human milk oligosaccharides for treating migraine in patients with inflammatory bowel syndrome
EP3478093A4 (en) 2016-07-01 2020-03-04 Evolve Biosystems, Inc. METHOD FOR FACILITATING MATURATION OF THE MAMMALIAN IMMUNE SYSTEM
AU2017307952A1 (en) * 2016-08-04 2018-11-29 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally Bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
US20180064739A1 (en) * 2016-09-06 2018-03-08 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180133287A1 (en) * 2016-11-14 2018-05-17 Mead Johnson Nutrition Company Nutritional compositions providing dietary management of colic
US10993970B2 (en) 2016-12-19 2021-05-04 Hany Z. ALY Medical-grade honey for growth enhancement of infants
WO2018206434A1 (en) 2017-05-09 2018-11-15 Nestec S.A. Synergistic production of butyrate associated with the complexity of hmos blend for use in infants or young children for health purposes
EP3634155A4 (en) 2017-05-12 2021-02-17 Axiom Foods Inc. RICE PRODUCTS AND SYSTEMS AND PROCESSES FOR THEIR PRODUCTION
MX2019013251A (es) 2017-05-24 2020-01-15 Société des Produits Nestlé SA Una composicion nutricional para usarse para mejorar la atencion y/o reducir la impulsividad.
KR20200084864A (ko) * 2017-10-04 2020-07-13 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 면역조절성 올리고사카라이드
US11541069B2 (en) * 2017-11-02 2023-01-03 Glycom A/S One or more HMOs for reducing or preventing fatigue and/or improving focus or concentration
WO2019106618A1 (en) * 2017-11-30 2019-06-06 Glycom A/S Mixture of hmos for treating wheat sensitivity
US11701404B2 (en) 2017-12-01 2023-07-18 Societe Des Produits Nestle S.A. Human milk fortifier composition
BR112020011236A2 (pt) 2017-12-08 2020-11-17 Jennewein Biotechnologie Gmbh lacto-n-fucopentaose seca por pulverização
CN111479573B (zh) * 2017-12-21 2024-05-24 雀巢产品有限公司 用于促进肠道肌肉生长和发育以及相关联的肠道能动性的组合物
AU2019243093B2 (en) * 2018-03-29 2022-10-06 Morinaga Milk Industry Co., Ltd. Nutritional composition, food/drink composition using nutritional composition, and modified milk powder using nutritional composition
EP3583858A1 (en) * 2018-06-20 2019-12-25 DuPont Nutrition Biosciences ApS Compositions for treating or preventing gut barrier dysfunction
GB2573539A (en) * 2018-05-09 2019-11-13 Mjn Us Holdings Llc Wellbeing supplement for postpartum maternal nutrition
EP3801557A4 (en) * 2018-05-30 2022-03-09 Evolve Biosystems Inc. COMPOSITIONS AND METHOD OF USE FOR BIFIDOBACTERIUM LONGUM SUBSP. COMPETENT FOR H5
EP3801067A4 (en) * 2018-06-01 2022-03-09 Evolve Biosystems Inc. COMPOSITIONS AND METHODS FOR ENHANCEMENT OF VERTEBRAL DEFENSE AND FOR STIMULATING, EXPANDING, STRETCHING OR RESETTING T-CELL REPERTOIRES
CN112218546B (zh) * 2018-06-25 2024-05-24 雀巢产品有限公司 包含用于改善、增强、促进或调节中枢神经系统中gaba能功能的人乳低聚糖的组合物
BR112021000377B1 (pt) 2018-07-12 2023-11-28 N.V. Nutricia Usos de 2-fucosil-lactose
CN110839702A (zh) * 2018-08-21 2020-02-28 内蒙古伊利实业集团股份有限公司 一种改善婴幼儿肠道菌群丰度和粪便气味的母乳低聚糖组合物及其应用
US20220054514A1 (en) * 2018-12-20 2022-02-24 Société des Produits Nestlé S.A. Human milk fortifier composition
MX2021005975A (es) * 2018-12-21 2021-07-15 Nestle Sa Una composicion nutricional que comprende 6'sl y lnt en combinacion para mejorar la funcion de la barrera gastrointestinal.
BR112021011344A2 (pt) * 2018-12-21 2021-08-31 Glycom A/S Composição e método para promoção de cura de barreira intestinal
WO2020178774A1 (en) * 2019-03-05 2020-09-10 Glycom A/S Human milk oligosaccharides for use in enhancing executive function
WO2020178362A1 (en) * 2019-03-05 2020-09-10 Société des Produits Nestlé S.A. A nutritional composition for use to enhance executive function
JP2022535718A (ja) * 2019-06-05 2022-08-10 グリコム・アクティーゼルスカブ 非セリアック小麦及び／又はグルテン過敏症を患っている患者の症状の処置において使用するためのヒトミルクオリゴ糖
JP2023502260A (ja) * 2019-11-20 2023-01-23 アボット・ラボラトリーズ クロストリジウム・ディフィシル感染症を治療する栄養組成物
CN112869167A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 副干酪乳杆菌k56提升肠道细菌感染抗性和肠道免疫力的应用
CA3163781A1 (en) * 2019-12-30 2021-07-08 Societe Des Produits Nestle S.A. Infant formula
JP7474596B2 (ja) * 2020-01-20 2024-04-25 森永乳業株式会社 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物
JP7516053B2 (ja) * 2020-01-20 2024-07-16 森永乳業株式会社 組成物並びに飲食品組成物、栄養組成物および調製乳
WO2021191469A1 (en) * 2020-03-27 2021-09-30 Basf Se Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto
US20240009216A1 (en) * 2020-11-10 2024-01-11 Societe Des Produits Nestle S.A. Nutritional composition
CN112514997B (zh) * 2020-11-30 2022-03-11 内蒙古伊利实业集团股份有限公司 改善肠道微环境健康的母乳低聚糖及其应用
EP4255220A1 (en) * 2020-12-01 2023-10-11 FrieslandCampina Nederland B.V. 2'-fucosyllactose for use in stimulating f. prausnitzii abundance
AU2022207078A1 (en) * 2021-01-12 2023-06-29 Prolacta Bioscience, Inc. Synbiotic treatment regimens
CN113796546A (zh) * 2021-09-13 2021-12-17 合生元（广州）健康产品有限公司 改善肠道屏障功能母乳低聚糖组合物及其应用
CN114223728B (zh) * 2021-11-30 2024-03-26 内蒙古伊利实业集团股份有限公司 含有益生元与益生菌的早产/低出生体重婴儿配方奶粉
WO2024184259A1 (en) * 2023-03-03 2024-09-12 Chr. Hansen A/S Composition comprising bifidobacterium animalis subsp. lactis strain and 2'-fucosyllactose

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE265207T1 (de) 1997-02-21 2004-05-15 Abbott Lab Verwendung von mehrfach ungesättigten fettsäuren zur vorbeugung von nekrotizierender enterokolitis
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
EP1255449B2 (en) * 2000-02-17 2016-06-08 Nestec S.A. Nutritional formulation containing prebiotic substances
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US9005682B2 (en) * 2006-03-07 2015-04-14 Nestec S.A. Synbiotic mixture
EP1993577B1 (en) * 2006-03-10 2014-02-12 N.V. Nutricia Use of non-digestable sacharides for giving an infant the best start after birth
US20070255598A1 (en) * 2006-03-29 2007-11-01 Mccarthy Nancy J Compliance aid, kits comprising the compliance aid, and methods of use
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
WO2009102193A1 (en) * 2008-02-12 2009-08-20 N.V. Nutricia A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants
EP2127661A1 (en) * 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
WO2010023178A1 (en) * 2008-08-28 2010-03-04 Chr. Hansen A/S Pharmaceuticals comprising a bacterial polysaccharide
CN102985105B (zh) * 2010-01-19 2016-03-09 雅培制药有限公司 包含合生元的营养配方

Also Published As

Publication number Publication date
NZ612386A (en) 2015-02-27
EP2658402A1 (en) 2013-11-06
MX2013007675A (es) 2013-07-29
TW201304692A (zh) 2013-02-01
CN103763940A (zh) 2014-04-30
CN103763940B (zh) 2015-10-14
WO2012092155A1 (en) 2012-07-05
SG191798A1 (en) 2013-08-30
US20120171166A1 (en) 2012-07-05
HK1256876A1 (zh) 2019-10-04
CA2822660A1 (en) 2012-07-05
BR112013016914A2 (pt) 2019-09-24
EP3335577A1 (en) 2018-06-20
CA2822660C (en) 2021-09-07

Similar Documents

Publication Publication Date Title
MX356184B (es) Fórmulación pediátrica sintética que comprende un probiótico.
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
PH12017500874A1 (en) Human milk oligosaccharides for modulating inflammation
MX2021014138A (es) Metodos para usar los oligosacaridos de leche humana para mejorar la salud respiratoria de las vias aereas.
MY174541A (en) Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MX2022011064A (es) Metodos para disminuir la incidencia de la enterocolitis necrotizante en bebes, infantes, o ni?os al usar los oligosacaridos de leche humana.
MY173726A (en) Synbiotics combination for brain improvement
MY186188A (en) Nutritional phytonutrient compositions
MX350782B (es) Galacto-oligosacaridos para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
MX352040B (es) Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas.
MY189329A (en) Mixture of non-digestible oligosaccharides for stimulating the immune system
SG178991A1 (en) Anti-gitr antibodies
MY175195A (en) Nutritional compositions
PH12014501782A1 (en) Maternal supplement to enhance immune system of an infant
PH12017500873A1 (en) Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
Boon-yasidhi et al. Adverse effects of risperidone in children with autism spectrum disorders in a naturalistic clinical setting

Legal Events

Date Code Title Description
FG Grant or registration